Alois B. Lang
Corporate Officer/Principal chez University of Bern
Profil
Alois B.
Lang was the founder of Kenta Biotech AG, where he held the title of Chief Scientific Officer in 2006.
Currently, he is a Professor-Immunology at the University of Bern.
Previously, he worked as the Chief Development Officer at GeNeuro SA (Switzerland).
Dr. Lang obtained his doctorate degree from the Swiss Federal Institute of Technology.
Postes actifs de Alois B. Lang
Sociétés | Poste | Début |
---|---|---|
University of Bern | Corporate Officer/Principal | - |
Anciens postes connus de Alois B. Lang
Sociétés | Poste | Fin |
---|---|---|
GENEURO SA | Corporate Officer/Principal | 31/12/2018 |
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Fondateur | - |
Formation de Alois B. Lang
Swiss Federal Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
GENEURO SA | Health Technology |
Entreprise privées | 1 |
---|---|
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Health Technology |